Advancement To Revolutionize Oral Drug Delivery
Zengen, Inc. announced today that its revolutionary drug delivery technology will be used in the new Chloraseptic® Relief Strips(tm), the only medicated oral strip for the treatment of sore throat. Zengens proprietary technology is the first to use drug active ingredients in an oral strip.
"We are excited to be part of the new generation of Chloraseptic products," said R. Steven Davidson, chief executive officer of Zengen. "Our technology holds promise to revolutionize the drug delivery industry because it marks the first time that drug active ingredients have been delivered utilizing an oral strip. This method is effective and convenient for consumers and may be more cost efficient for manufacturers."
The medicated oral strip is structured as a proprietary bilayer system. This system eliminates the use of irritating solvents and reduces damage due to heat and moisture, maintaining the integrity and efficacy of the active ingredients.
Certain auxiliary compounds used with the bilayer system can assist with rate of dissolution, water solubility, mucous adhesion and coating on the exterior film layer. For instance, depending on the auxiliary compounds used, Zengens oral strips can be manufactured to dissolve quickly or over an extended period of time, regulating the release of active material.
Previous technologies have proven too harsh, exposing the medical compound to extreme heat, moisture, compromising solvents and other irritants. With the creation of Chloraseptic Relief Strips, Zengen has established a new process which prevents the exposure to these harmful irritants and incorporates additional compounds to make the strips more suitable for various drug delivery needs.
"Chloraseptic Relief Strips bring true innovation to the cough/cold category and are a fitting extension of the Chloraseptic product line," said Elise Donahue, president and chief operating officer of Prestige Brands International. "Zengens technology has allowed us to make our product more convenient, accessible and modern for our consumers."
About Chloraseptic Relief Strips
New Chloraseptic Relief Strips are the first and only product of its kind to provide immediate and convenient relief of sore throat pain in an oral strip. The oral strips contain the active ingredients benzocaine and menthol. Chloraseptic Relief Strips will be available in major retail markets and drug stores beginning in September, 2003. The strips will be sold in two 20-count packs at a suggested retail price of $5.29.
About Zengen, Inc.
Zengen, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative products to treat and prevent infection and inflammation through application of its proprietary peptide technologies. Zengens novel molecules offer broad-based anti-infective and anti-inflammatory solutions for multiple diseases and disorders, ranging from yeast infection to transplantation, and have the potential to significantly alter the way these diseases are treated. Through its wholly-owned subsidiary, InnoZen, Inc., Zengen develops and markets, or outlicenses, over-the-counter health products. In June 2003, InnoZen launched new OptiZen lubricating eye drops for instant relief from symptoms associated with Computer Vision Syndrome including eye dryness, burning and irritation. For more information about Zengen, please visit www.zengen.com
About Prestige Brands International
Prestige Brands is a consumer products company that was formed in 1999 for the purpose of buying and marketing popular consumer products. Prestiges first acquisition was Prell Shampoo, which the company purchased in November 1999. Subsequently, Prestige Brands purchased Chloraseptic Throat Sprays and Lozenges in March 2000, Comet Cleanser in 2001, and the Clear Eyes and Murine brands of eye drops and ear care products in 2003. Prestiges expertise is in marketing well-known brands to consumers via targeted advertising and promotion as well as identifying and developing new innovative line extensions that better meet consumers needs.
Kumiko Hakushi | Ruder Finn, Inc.
Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania
The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
17.01.2017 | Earth Sciences
17.01.2017 | Materials Sciences
17.01.2017 | Architecture and Construction